Analysts’ Recent Ratings Updates for Alignment Healthcare (ALHC)

A number of research firms have changed their ratings and price targets for Alignment Healthcare (NASDAQ: ALHC):

• 11/2/2026 – Alignment Healthcare had its price target lowered by TD Cowen from $12.00 to $10.00. They now have a “buy” rating on the stock.
• 10/30/2026 – Alignment Healthcare was downgraded by Weiss Ratings from “hold (c-)” to “sell (d)”.
• 10/30/2026 – Alignment Healthcare had its “overweight” rating reaffirmed by Piper Sandler. They now have a $15.00 price target on the stock.
• 10/30/2026 – Alignment Healthcare had its price target lowered by UBS Group from $9.00 to $8.00. They now have a “neutral” rating on the stock.
• 10/30/2026 – Alignment Healthcare had its price target lowered by JPMorgan Chase & Co. from $10.00 to $8.00. They now have an “overweight” rating on the stock.
• 10/30/2026 – Alignment Healthcare had its price target lowered by Barclays from $10.00 to $9.00. They now have an “equal weight” rating on the stock.
• 10/30/2026 – Alignment Healthcare was downgraded by KeyCorp from “overweight” to “sector weight”.
• 10/28/2026 – Alignment Healthcare is now covered by Needham & Company LLC. They set a “hold” rating on the stock.
• 10/22/2026 – Alignment Healthcare had its “buy” rating reaffirmed by The Goldman Sachs Group. They now have a $12.00 price target on the stock.
• 10/12/2026 – Alignment Healthcare had its price target lowered by UBS Group from $22.00 to $9.00. They now have a “neutral” rating on the stock.
• 10/12/2026 – Alignment Healthcare had its “outperform” rating reaffirmed by Raymond James Financial.
• 10/12/2026 – Alignment Healthcare had its price target lowered by UBS Group from $22.00 to $9.00. They now have a “hold” rating on the stock.
• 10/12/2026 – Alignment Healthcare had its price target lowered by TD Cowen from $21.00 to $12.00. They now have a “buy” rating on the stock.
• 10/9/2026 – Alignment Healthcare was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”.
• 10/9/2026 – Alignment Healthcare was given a new $9.00 price target by Scotiabank.
• 10/9/2026 – Alignment Healthcare was downgraded by William Blair from “outperform” to “market perform”.
• 10/9/2026 – Alignment Healthcare had its price target lowered by JPMorgan Chase & Co. from $22.00 to $10.00. They now have an “overweight” rating on the stock.
• 10/9/2026 – Alignment Healthcare had its price target lowered by KeyCorp from $28.00 to $12.00. They now have an “overweight” rating on the stock.
• 10/6/2026 – Alignment Healthcare had its price target lowered by Barclays from $16.00 to $10.00. They now have an “equal weight” rating on the stock.
• 9/25/2026 – Alignment Healthcare was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
• 9/16/2026 – Alignment Healthcare had its “buy” rating reaffirmed by TD Cowen.

Alignment Healthcare Price Performance

ALHC stock traded down $0.14 during midday trading on Thursday, reaching $7.55. The company had a trading volume of 1,063,329 shares, compared to its average volume of 5,609,616. Alignment Healthcare, Inc. has a 1-year low of $6.01 and a 1-year high of $25.12. The stock has a 50 day moving average price of $8.91 and a 200-day moving average price of $16.22. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.71 and a quick ratio of 1.71. The company has a market capitalization of $1.58 billion, a price-to-earnings ratio of 58.12 and a beta of 1.07.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings data on Thursday, October 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.04). Alignment Healthcare had a net margin of 0.59% and a return on equity of 12.46%. The firm had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.31 billion. During the same period in the prior year, the company posted $0.02 earnings per share. The business’s revenue for the quarter was up 36.7% on a year-over-year basis. Equities research analysts expect that Alignment Healthcare, Inc. will post -0.03 earnings per share for the current year.

Insider Activity

In related news, EVP Joseph Konowiecki sold 23,511 shares of Alignment Healthcare stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $8.61, for a total value of $202,429.71. Following the transaction, the executive vice president directly owned 1,080,305 shares of the company’s stock, valued at $9,301,426.05. This trade represents a 2.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, President Dawn Maroney sold 122,707 shares of the business’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $12.68, for a total transaction of $1,555,924.76. Following the transaction, the president owned 794,606 shares of the company’s stock, valued at approximately $10,075,604.08. This represents a 13.38% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 763,967 shares of company stock worth $9,506,250. Insiders own 5.20% of the company’s stock.

Alignment Healthcare, Inc. is a technology-enabled healthcare company focused primarily on serving older adults through Medicare Advantage plans. Its health plans, offered under the Alignment Health Plan name, combine insurance coverage with care coordination and support intended to address members’ medical and everyday health needs. The company uses a care model that includes personalized care teams, member support and technology to help coordinate services across providers. Its Medicare Advantage offerings include plan options such as HMO and PPO products, with availability and benefits varying by location.